Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Divi's Laboratories Limited, widely recognised as Divis Laboratories or Divi's Lab, is a prominent pharmaceutical company headquartered in Hyderabad, India. Founded in 1990, it has evolved into a global leader in the pharmaceutical sector, leveraging over three decades of operational excellence.
Specialising in pharmaceutical research and development services, Divis excels in the large-scale manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical Ingredients. Its core offering includes custom synthesis for global pharmaceutical companies, distinguished by high-quality, cost-effective production and robust R&D capabilities.
+18 vs industry average
Divis Laboratories’s score of 51 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Divi's Laboratories, an India-based research and development services company, reported total Scope 1, 2, and 3 emissions of approximately 1.95 billion kg CO2e in 2026. This includes about 371.7 million kg CO2e from Scope 1, 378.5 million kg CO2e from Scope 2, and 1.2 billion kg CO2e from Scope 3.
In 2025, the company's total reported emissions were approximately 1.59 billion kg CO2e, with Scope 1 emissions at around 339.9 million kg CO2e, Scope 2 at about 357.8 million kg CO2e, and Scope 3 at approximately 897 million kg CO2e. For 2024, total emissions were roughly 1.52 billion kg CO2e, comprising around 363.2 million kg CO2e from Scope 1, 326 million kg CO2e from Scope 2, and 832.2 million kg CO2e from Scope 3. In 2023, Divi's Laboratories reported Scope 1 emissions of approximately 86,940 kg CO2e and Scope 2 emissions of about 64,860 kg CO2e. No Scope 3 data was disclosed for this year. The earliest reported data in 2022 showed Scope 1 emissions of roughly 382.7 million kg CO2e and Scope 2 emissions of about 370.7 million kg CO2e, with no Scope 3 data.
Divi's Laboratories has set ambitious climate commitments, validated by the Science Based Targets initiative (SBTi). The company aims to achieve net-zero greenhouse gas emissions across its entire value chain by FY2050. Near-term targets include reducing absolute Scope 1 and 2 GHG emissions by 58.8% by FY2034 from a FY2024 base year. Additionally, Divi's Laboratories commits to reducing absolute Scope 3 GHG emissions by 35% within the same timeframe. For its long-term targets, the company plans to reduce absolute Scope 1 and 2 GHG emissions by 90% by FY2050 from a FY2024 base year, with a corresponding 90% reduction in absolute Scope 3 GHG emissions within the same period. These targets are consistent with limiting global warming to 1.5°C. The company also has an internal target to reduce intensity-based GHG (Scope 1 & Scope 2) emissions by 25% by 2030 from a 2023 baseline.
2050
90% reduction in Scope 1
Divi's Laboratories Limited commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2024 base year.* *The target bound…
2050
90% reduction in scope 3 total
Divi's Laboratories Limited also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.
2050
90% reduction in Scope 2
Divi's Laboratories Limited commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2024 base year.* *The target bound…
See all 7 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Divis Laboratories’s sustainability data and climate commitments
Data year: 2026
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more